New Children´s Hospital, and Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Pediatr Res. 2022 Sep;92(3):776-782. doi: 10.1038/s41390-021-01794-y. Epub 2021 Oct 30.
Caffeine is widely used in preterm infants for apnea control. It has no effect on sleep in the only existing polysomnographic study including ten preterm infants Behavioral and polygraphic studies have conflicting results.
We studied 21 late-preterm infants at a median gestational age of 36 weeks. Polysomnography was performed twice, at baseline on day 1 and on the day after the onset of caffeine treatment (20 mg/kg loading and 5 mg/kg morning maintenance dose).
Caffeine acted short term as a breathing stimulant with reduction of apneas, improved baseline SpO (p < 0.001), and decreased 95 percentile of end-tidal carbon dioxide level (p < 0.01). It also increased arousal frequency to SpO desaturations of more than 5% (p < 0.001). Caffeine did not affect sleep stage distribution, sleep efficiency, frequency of sleep stage transitions, appearance of REM periods, or the high number of spontaneous arousals. The median spontaneous arousal count was 18 per hour at baseline, and 16 per hour during caffeine treatment (p = 0.88).
In late-preterm infants, caffeine has a clear short-term respiratory stimulant effect, and it increases the arousal frequency to hypoxia. However, caffeine does not appear to act as a central nervous system stimulant, and it has no acute effect on sleep quality.
Effects of caffeine on sleep in preterm infants has previously been investigated with only one full polysomnographic study including ten preterm infants. The study showed no effect. The current study shows that caffeine acts short term as a respiratory stimulant and increases arousal frequency to hypoxia. Although a potent central nervous system (CNS) stimulant in adults, caffeine does not seem to have similar acute CNS effect in late-preterm infants. The onset of caffeine treatment has no short-term effect on sleep stage distribution, sleep efficiency, frequency of sleep stage transitions, appearance of REM periods, or the high number of spontaneous arousals.
咖啡因被广泛用于早产儿的呼吸暂停控制。唯一一项包含 10 名早产儿的多导睡眠图研究表明,咖啡因对睡眠没有影响。行为和多导睡眠图研究结果存在冲突。
我们研究了 21 名胎龄中位数为 36 周的晚期早产儿。在基线时(第 1 天)和咖啡因治疗开始后(20mg/kg 负荷剂量和 5mg/kg 晨起维持剂量)进行了两次多导睡眠图检查。
咖啡因短期作用为呼吸兴奋剂,可减少呼吸暂停,改善基础血氧饱和度(p<0.001),并降低 95%呼气末二氧化碳水平(p<0.01)。它还增加了对血氧饱和度下降超过 5%的觉醒频率(p<0.001)。咖啡因对睡眠分期分布、睡眠效率、睡眠分期转换频率、出现 REM 期或自发性觉醒次数增多均无影响。基线时自发性觉醒次数中位数为每小时 18 次,咖啡因治疗时为每小时 16 次(p=0.88)。
在晚期早产儿中,咖啡因具有明确的短期呼吸兴奋剂作用,并增加了对缺氧的觉醒频率。然而,咖啡因似乎不作为中枢神经系统兴奋剂,对睡眠质量没有急性影响。
以前只有一项包含 10 名早产儿的多导睡眠图研究调查了咖啡因对早产儿睡眠的影响。该研究表明没有影响。本研究表明,咖啡因短期作用为呼吸兴奋剂,并增加了对缺氧的觉醒频率。虽然咖啡因在成人中是一种有效的中枢神经系统(CNS)兴奋剂,但它似乎对晚期早产儿没有类似的急性 CNS 作用。咖啡因治疗的开始对睡眠分期分布、睡眠效率、睡眠分期转换频率、出现 REM 期或自发性觉醒次数增多均无短期影响。